Reuters logo
BRIEF-Intellipharmaceutics signs an exclusive license deal with Mallinckrodt
2016年10月11日 / 晚上9点57分 / 1 年前

BRIEF-Intellipharmaceutics signs an exclusive license deal with Mallinckrodt

Oct 11 (Reuters) - Intellipharmaceutics International Inc

* Intellipharmaceutics signs an exclusive license and commercial supply agreement with mallinckrodt

* Intellipharmaceutics international inc - Intellipharmaceutics will receive a non-refundable upfront payment of US$3 million in October 2016

* Intellipharmaceutics International Inc - has agreed to manufacture and supply licensed products exclusively for mallinckrodt

* Intellipharmaceutics international inc - Mallinckrodt has agreed that Intellipharmaceutics will be its sole supplier of licensed products marketed in u.s

* Intellipharmaceutics International- agreement provides for company to have long-term profit sharing arrangement with respect to licensed products Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below